257 related articles for article (PubMed ID: 30502453)
1. The crystalline salt form of a selected candidate drug showed photo-, thermal- and humidity induced form transitions.
Sigfridsson K; Lindsjö M; Paulsson S
Eur J Pharm Sci; 2019 Feb; 128():128-136. PubMed ID: 30502453
[TBL] [Abstract][Full Text] [Related]
2. Salt formation improved the properties of a candidate drug during early formulation development.
Sigfridsson K; Ahlqvist M; Lindsjö M; Paulsson S
Eur J Pharm Sci; 2018 Jul; 120():162-171. PubMed ID: 29730322
[TBL] [Abstract][Full Text] [Related]
3. Preparation of an amorphous sodium furosemide salt improves solubility and dissolution rate and leads to a faster Tmax after oral dosing to rats.
Nielsen LH; Gordon S; Holm R; Selen A; Rades T; Müllertz A
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):942-51. PubMed ID: 24075980
[TBL] [Abstract][Full Text] [Related]
4. Undesired co-amorphisation of indomethacin and arginine during combined storage at high humidity conditions.
Petry I; Löbmann K; Grohganz H; Rades T; Leopold CS
Int J Pharm; 2018 Jun; 544(1):172-180. PubMed ID: 29669257
[TBL] [Abstract][Full Text] [Related]
5. Preformulation investigation and challenges; salt formation, salt disproportionation and hepatic recirculation.
Sigfridsson K; Nilsson L; Ahlqvist M; Andersson T; Granath AK
Eur J Pharm Sci; 2017 Jun; 104():262-272. PubMed ID: 28366653
[TBL] [Abstract][Full Text] [Related]
6. Relative humidity-temperature transition boundaries for anhydrous β-caffeine and caffeine hydrate crystalline forms.
Allan MC; Owens B; Mauer LJ
J Food Sci; 2020 Jun; 85(6):1815-1826. PubMed ID: 32449950
[TBL] [Abstract][Full Text] [Related]
7. Stability of polymorphic forms of ranitidine hydrochloride.
Wu V; Rades T; Saville DJ
Pharmazie; 2000 Jul; 55(7):508-12. PubMed ID: 10944778
[TBL] [Abstract][Full Text] [Related]
8. Mapping the solid-state properties of crystalline lysozyme during pharmaceutical unit-operations.
Mohammad MA; Grimsey IM; Forbes RT
J Pharm Biomed Anal; 2015 Oct; 114():176-83. PubMed ID: 26068908
[TBL] [Abstract][Full Text] [Related]
9. Preformulation evaluation of AZD1305, an oxabispidine intended for oral and intravenous treatment.
Sigfridsson K; Lundqvist R; Ohlson K
Drug Dev Ind Pharm; 2012 Jan; 38(1):19-31. PubMed ID: 21707325
[TBL] [Abstract][Full Text] [Related]
10. Characterization of Phase Separation Propensity for Amorphous Spray Dried Dispersions.
McNamara D; Yin S; Pan D; Crull G; Timmins P; Vig B
Mol Pharm; 2017 Feb; 14(2):377-385. PubMed ID: 28068097
[TBL] [Abstract][Full Text] [Related]
11. A preformulation evaluation of a photosensitive surface active compound, explaining concentration dependent degradation.
Sigfridsson K; Carlsson KE
Eur J Pharm Sci; 2017 Nov; 109():650-656. PubMed ID: 28736127
[TBL] [Abstract][Full Text] [Related]
12. Investigation of recrystallization of amorphous trehalose through hot-humidity stage X-ray powder diffraction.
Jójárt-Laczkovich O; Katona G; Aigner Z; Szabó-Révész P
Eur J Pharm Sci; 2016 Dec; 95():145-151. PubMed ID: 27496047
[TBL] [Abstract][Full Text] [Related]
13. Crystal forms of the hydrogen oxalate salt of o-desmethylvenlafaxine.
Dichiarante E; Curzi M; Giaffreda SL; Grepioni F; Maini L; Braga D
J Pharm Pharmacol; 2015 Jun; 67(6):823-9. PubMed ID: 25644936
[TBL] [Abstract][Full Text] [Related]
14. Selection of optimal hydrate/solvate forms of a fibrinogen receptor antagonist for solid dosage development.
Bray ML; Jahansouz H; Kaufman MJ
Pharm Dev Technol; 1999 Jan; 4(1):81-7. PubMed ID: 10027216
[TBL] [Abstract][Full Text] [Related]
15. Influence of pH and method of crystallization on the solid physical form of indomethacin.
Dubbini A; Censi R; Martena V; Hoti E; Ricciutelli M; Malaj L; Di Martino P
Int J Pharm; 2014 Oct; 473(1-2):536-44. PubMed ID: 25064728
[TBL] [Abstract][Full Text] [Related]
16. Physical characterization of nedocromil sodium hydrates.
Khankari R; Chen L; Grant DJ
J Pharm Sci; 1998 Sep; 87(9):1052-61. PubMed ID: 9724554
[TBL] [Abstract][Full Text] [Related]
17. Solid state characterization of dehydroepiandrosterone.
Chang LC; Caira MR; Guillory JK
J Pharm Sci; 1995 Oct; 84(10):1169-79. PubMed ID: 8801330
[TBL] [Abstract][Full Text] [Related]
18. Moisture sorption behavior of selected bulking agents used in lyophilized products.
Fakes MG; Dali MV; Haby TA; Morris KR; Varia SA; Serajuddin AT
PDA J Pharm Sci Technol; 2000; 54(2):144-9. PubMed ID: 10822985
[TBL] [Abstract][Full Text] [Related]
19. Disproportionation of a crystalline citrate salt of a developmental pharmaceutical compound: characterization of the kinetics using pH monitoring and online Raman spectroscopy plus quantitation of the crystalline free base form in binary physical mixtures using FT-Raman, XRPD and DSC.
Skrdla PJ; Zhang D
J Pharm Biomed Anal; 2014 Mar; 90():186-91. PubMed ID: 24378612
[TBL] [Abstract][Full Text] [Related]
20. Thermodynamic stability considerations for isostructural dehydrates.
Murphy BJ; Casteel MJ; Samas B; Krzyzaniak JF
J Pharm Sci; 2012 Apr; 101(4):1486-95. PubMed ID: 22262468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
